Yifan Hou Selected Research

RNA Demethylase AlkB Homolog 5

1/2022	RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways.
1/2022	RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yifan Hou Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 01/2019
2	Multiple Myeloma 01/2022 - 01/2022
1	Carcinogenesis 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 08/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2019
1	Carcinoma (Carcinomatosis) 02/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

2	RNA Demethylase AlkB Homolog 5IBA 01/2022 - 01/2022
2	Peptide LibraryIBA 01/2021 - 02/2019
2	Peptides (Polypeptides)IBA 01/2021 - 02/2019
2	Pharmaceutical PreparationsIBA 08/2020 - 02/2019
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2022
1	venetoclaxIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	5-Lipoxygenase-Activating ProteinsIBA 01/2021
1	Annexin A2 (Annexin II)IBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2019
1	Lasers (Laser) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021